Ethnicity-specific claims have become paramount to product adoption in key EMEA markets. Quantifying cell pigmentation with traditional methods, such as melanin extraction, is time consuming.
Taking advantage on recent advances in pluripotent stem cell biology and flow cytometry automation, our R&D Team has developed a simple and straightforward in vitro assay using melanocytes derived from human induced pluripotent stem cells (iPSC) and high-throughout flow cytometry to screen and classify molecules/compounds according to their ability to modulate pigment production.
The platform has been validated in a variety of melanocytes from African, Caucasian or Asian genetic background and yielded confirmed Hits.
Brigitte Onteniente , President
brigitte.onteniente@phenocell.com
Tel: +33(0)4 89 35 43 32
In a world where life expectancy continues to increase, the concept of longevity no longer…
The Korea Institute of Dermatological Sciences has been conducting safety and efficacy evaluations, in-vitro evaluations,…
CLAIM® is an Argentina-based Contract Research Organization (CRO) specializing in the design, development, and execution…